Aehr Test Systems (AEHR) Director Laura Oliphant Sells 1,717 Shares

What Happened

• Laura Oliphant, a director of Aehr Test Systems (AEHR), sold 1,717 shares in an open-market transaction on August 12, 2026 at $133.00 per share, for total proceeds of $228,361. This was a sale (not a purchase or option exercise), which is often routine insider liquidity rather than a definitive signal about company prospects.

Key Details

• Transaction date and price: 2026-08-12 at $133.00 per share
• Shares sold: 1,717; Gross proceeds: $228,361
• Filing date / timeliness: Form 4 filed 2026-08-13 (timely; within required reporting window)
• Shares owned after transaction: Not specified in the provided filing
• Footnote: The filing notes the reported amount includes shares subject to unvested restricted stock units (these are reported in the ownership amount but remain subject to vesting/transfer restrictions)

Context

• This was an open-market sale by a director. Sales by insiders can reflect routine portfolio management or tax/liquidity needs and do not, by themselves, prove a change in sentiment about the company. The filing does not indicate a 10% owner status, option exercise, or a 10b5-1 plan.